India will administer injections to three million frontline workers in phase one. There are 3,006 session sites across the country, where every 100 recipients will receive either of the two indigenous vaccines from India, Covaxin or Covishield. Each beneficiary must receive two doses of the same vaccine, 28 days apart.
On the disintegration of Covishield and Covaxin, the Ministry data showed that while the first vaccine, developed by Oxford-AstraZeneca and manufactured by the Serum Institute of Pune, had been supplied to all states and territories of the Union, the developed Covaxin It was administered locally in “clinical trial mode” in 12 states, including the national capital. Each session site could administer only one of the two vaccines.
During the vaccination campaign, Maharashtra recorded 14 cases of adverse events, however none of them were fatal. State officials currently studying them.
Since the pandemic hit India in early 2020, more than one crore and 5.42 lakh people have been infected with the disease, while about 1.52 lakh have died. Kerala and Maharashtra currently have the highest number of daily cases.
.
